UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
82.59 -0.22 (-0.27%) GOLD FUTURES
2,337.40 -1.00 (-0.04%) DOW
37,970.67 -490.25 (-1.27%) Bitcoin GBP
51,324.20 -189.70 (-0.37%)
ORIC Pharmaceuticals, Inc. (ORIC)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:31PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 544.40M |
| Enterprise value | 338.96M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 2.43 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.09 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.03 |
| 52-week change 3 | 59.06% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 16.65 |
| 52-week low 3 | 4.90 |
| 50-day moving average 3 | 12.21 |
| 200-day moving average 3 | 9.20 |
Share statistics
| Avg vol (3-month) 3 | 567.85k |
| Avg vol (10-day) 3 | 395.85k |
| Shares outstanding 5 | 67.38M |
| Implied shares outstanding 6 | 67.38M |
| Float 8 | 37.08M |
| % held by insiders 1 | 9.53% |
| % held by institutions 1 | 88.43% |
| Shares short (15 Apr 2024) 4 | 9.42M |
| Short ratio (15 Apr 2024) 4 | 14.99 |
| Short % of float (15 Apr 2024) 4 | 15.20% |
| Short % of shares outstanding (15 Apr 2024) 4 | 13.99% |
| Shares short (prior month 15 Mar 2024) 4 | 6.93M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -27.74% |
| Return on equity (ttm) | -45.11% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -109.75M |
| Net income avi to common (ttm) | -100.7M |
| Diluted EPS (ttm) | -1.96 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 208.19M |
| Total cash per share (mrq) | 3.09 |
| Total debt (mrq) | 10.21M |
| Total debt/equity (mrq) | 4.56% |
| Current ratio (mrq) | 10.39 |
| Book value per share (mrq) | 4.08 |
Cash flow statement
| Operating cash flow (ttm) | -85.69M |
| Levered free cash flow (ttm) | -49.08M |
© 2024 Yahoo. All rights reserved.